These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1691885

  • 21. Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells.
    McKiel V, Gu Z, Wainberg MA, Hiscott J.
    J Interferon Cytokine Res; 1995 Oct; 15(10):849-55. PubMed ID: 8564706
    [Abstract] [Full Text] [Related]

  • 22. Rapid detection of HIV-1 in clinical samples by co-culture with heat-shocked cells.
    Re MC, Furlini G, La Placa M.
    J Virol Methods; 1989 Dec; 26(3):313-7. PubMed ID: 2482842
    [Abstract] [Full Text] [Related]

  • 23. HIV-1 sensitivity to zidovudine: a consensus culture technique validated by genotypic analysis of the reverse transcriptase.
    Brun-Vézinet F, Ingrand D, Deforges L, Gochi K, Ferchal F, Schmitt MP, Jung M, Masquelier B, Aubert J, Buffet-Janvresse C.
    J Virol Methods; 1992 May; 37(2):177-88. PubMed ID: 1375948
    [Abstract] [Full Text] [Related]

  • 24. Infection of human thymic lymphocytes by HIV-1.
    Tremblay M, Numazaki K, Goldman H, Wainberg MA.
    J Acquir Immune Defic Syndr (1988); 1990 May; 3(4):356-60. PubMed ID: 1690286
    [Abstract] [Full Text] [Related]

  • 25. A critical analysis of the pharmacology of AZT and its use in AIDS.
    Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer D, Alphonso H, Miller T.
    Curr Med Res Opin; 1999 May; 15 Suppl 1():S1-45. PubMed ID: 11594171
    [Abstract] [Full Text] [Related]

  • 26. [Inhibition of human immunodeficiency virus replication by azidothymidine (Azitidín Lachema) in cultured cells].
    Schmidtmayerová H, Mayer V.
    Bratisl Lek Listy; 1993 Feb; 94(2):76-80. PubMed ID: 7689030
    [Abstract] [Full Text] [Related]

  • 27. The prognostic value of plasma viremia in HIV-infected patients under AZT treatment: a two-year follow-up study.
    Ruffault A, Michelet C, Jacquelinet C, Guist'hau O, Genetet N, Bariou C, Colimon R, Cartier F.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul 01; 9(3):243-8. PubMed ID: 7788423
    [Abstract] [Full Text] [Related]

  • 28. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK, Hirsch MS, Merrill DP, Bechtel LJ, Eron JJ, Kaplan JC, D'Aquila RT.
    Nature; 1993 Feb 18; 361(6413):650-4. PubMed ID: 7679778
    [Abstract] [Full Text] [Related]

  • 29. Human immunodeficiency virus type 1 infection of endothelial cells in vitro.
    Re MC, Furlini G, Cenacchi G, Preda P, La Placa M.
    Microbiologica; 1991 Apr 18; 14(2):149-52. PubMed ID: 1713288
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
    Smith MS, Thresher RJ, Pagano JS.
    Antimicrob Agents Chemother; 1991 Jan 18; 35(1):62-7. PubMed ID: 1707604
    [Abstract] [Full Text] [Related]

  • 31. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV.
    Lee AW, Mitra D, Laurence J.
    AIDS Res Hum Retroviruses; 1997 Sep 20; 13(14):1235-42. PubMed ID: 9310291
    [Abstract] [Full Text] [Related]

  • 32. DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity.
    Arts EJ, Mak J, Kleiman L, Wainberg MA.
    J Gen Virol; 1994 Jul 20; 75 ( Pt 7)():1605-13. PubMed ID: 7517431
    [Abstract] [Full Text] [Related]

  • 33. [Investigation of AZT susceptibility of sequential HIV-1 isolates from patients treated with ddI after long-term therapy with AZT].
    Saito T, Kondo M, Ito A, Nagao T, Hayashi T, Watanabe S, Imai M.
    Kansenshogaku Zasshi; 1994 Jul 20; 68(7):819-23. PubMed ID: 8089546
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
    Gendelman HE, Baca L, Turpin JA, Kalter DC, Hansen BD, Orenstein JM, Friedman RM, Meltzer MS.
    AIDS Res Hum Retroviruses; 1990 Aug 20; 6(8):1045-9. PubMed ID: 2121192
    [Abstract] [Full Text] [Related]

  • 36. Quantitative RNA and DNA gene amplification can rapidly monitor HIV infection and antiviral activity in cell cultures.
    Winters MA, Holodniy M, Katzenstein DA, Merigan TC.
    PCR Methods Appl; 1992 May 20; 1(4):257-62. PubMed ID: 1477661
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of HIV replication in lymphocyte cultures of virus-positive subjects in the presence of sho-saiko-to, an oriental plant extract.
    Buimovici-Klein E, Mohan V, Lange M, Fenamore E, Inada Y, Cooper LZ.
    Antiviral Res; 1990 May 20; 14(4-5):279-86. PubMed ID: 1708225
    [Abstract] [Full Text] [Related]

  • 38. [Investigation of AZT sensitivity of HIV-1 isolates from patients treated with AZT].
    Saito T, Kondo M, Ito A, Nagao T, Imai M.
    Kansenshogaku Zasshi; 1993 Apr 20; 67(4):311-4. PubMed ID: 8315299
    [Abstract] [Full Text] [Related]

  • 39. Natural resistance of human immunodeficiency virus type 2 to zidovudine.
    Reid P, MacInnes H, Cong ME, Heneine W, García-Lerma JG.
    Virology; 2005 Jun 05; 336(2):251-64. PubMed ID: 15892966
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.